Men with prostate cancer might survive longer by regularly taking aspirin, a new study suggests. While there have been other studies showing regular use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) seems to reduce the risk of developing various cancers, including prostate cancer, this is one of the first to suggest that such drugs may help men with prostate cancer live longer. The study led by Dr. K Khanh H. Nguyen, a radiation oncologist at Fox Chase Cancer Center was presented today at the 46th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO).
